nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—melanoma	0.259	1	CbGaD
Estropipate—ALB—Vemurafenib—melanoma	0.125	0.263	CbGbCtD
Estropipate—CYP1A2—Carmustine—melanoma	0.0949	0.199	CbGbCtD
Estropipate—CYP1A2—Vemurafenib—melanoma	0.075	0.157	CbGbCtD
Estropipate—CYP3A4—Temozolomide—melanoma	0.0717	0.15	CbGbCtD
Estropipate—CYP1A2—Dacarbazine—melanoma	0.0575	0.12	CbGbCtD
Estropipate—CYP3A4—Vemurafenib—melanoma	0.0393	0.0823	CbGbCtD
Estropipate—CYP3A4—Docetaxel—melanoma	0.0135	0.0283	CbGbCtD
Estropipate—Estramustine—MAP2—melanoma	0.00317	0.558	CrCbGaD
Estropipate—Cyst—Docetaxel—melanoma	0.00092	0.00609	CcSEcCtD
Estropipate—Oedema peripheral—Vemurafenib—melanoma	0.000895	0.00592	CcSEcCtD
Estropipate—Vaginal infection—Temozolomide—melanoma	0.000873	0.00578	CcSEcCtD
Estropipate—Injury—Bleomycin—melanoma	0.000866	0.00573	CcSEcCtD
Estropipate—Neoplasm—Carmustine—melanoma	0.000866	0.00572	CcSEcCtD
Estropipate—Erythema multiforme—Vemurafenib—melanoma	0.000859	0.00568	CcSEcCtD
Estropipate—Eye disorder—Vemurafenib—melanoma	0.00085	0.00562	CcSEcCtD
Estropipate—Cardiac disorder—Vemurafenib—melanoma	0.000844	0.00558	CcSEcCtD
Estropipate—Neoplasm—Temozolomide—melanoma	0.000836	0.00553	CcSEcCtD
Estropipate—Angiopathy—Vemurafenib—melanoma	0.000825	0.00545	CcSEcCtD
Estropipate—Neuritis—Docetaxel—melanoma	0.000824	0.00545	CcSEcCtD
Estropipate—Mediastinal disorder—Vemurafenib—melanoma	0.000819	0.00542	CcSEcCtD
Estropipate—Cerebrovascular accident—Bleomycin—melanoma	0.000812	0.00537	CcSEcCtD
Estropipate—Alopecia—Vemurafenib—melanoma	0.000803	0.00531	CcSEcCtD
Estropipate—Thrombophlebitis—Carmustine—melanoma	0.000803	0.00531	CcSEcCtD
Estropipate—Malnutrition—Vemurafenib—melanoma	0.000791	0.00523	CcSEcCtD
Estropipate—Erythema—Vemurafenib—melanoma	0.000791	0.00523	CcSEcCtD
Estropipate—Thrombophlebitis—Temozolomide—melanoma	0.000776	0.00513	CcSEcCtD
Estropipate—Back pain—Vemurafenib—melanoma	0.000765	0.00506	CcSEcCtD
Estropipate—Injury—Carmustine—melanoma	0.000756	0.005	CcSEcCtD
Estropipate—Amenorrhoea—Docetaxel—melanoma	0.0007	0.00463	CcSEcCtD
Estropipate—Purpura—Temozolomide—melanoma	0.000697	0.00461	CcSEcCtD
Estropipate—Cough—Vemurafenib—melanoma	0.000691	0.00457	CcSEcCtD
Estropipate—Bone disorder—Docetaxel—melanoma	0.000681	0.0045	CcSEcCtD
Estropipate—Arthralgia—Vemurafenib—melanoma	0.000674	0.00445	CcSEcCtD
Estropipate—Myalgia—Vemurafenib—melanoma	0.000674	0.00445	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000669	0.00442	CcSEcCtD
Estropipate—Anaphylactic shock—Vemurafenib—melanoma	0.000646	0.00427	CcSEcCtD
Estropipate—Infection—Vemurafenib—melanoma	0.000642	0.00424	CcSEcCtD
Estropipate—Mood swings—Temozolomide—melanoma	0.000636	0.00421	CcSEcCtD
Estropipate—Inflammation—Docetaxel—melanoma	0.000634	0.00419	CcSEcCtD
Estropipate—Nervous system disorder—Vemurafenib—melanoma	0.000633	0.00419	CcSEcCtD
Estropipate—Skin disorder—Vemurafenib—melanoma	0.000627	0.00415	CcSEcCtD
Estropipate—Blood pressure increased—Docetaxel—melanoma	0.000615	0.00407	CcSEcCtD
Estropipate—Pulmonary embolism—Docetaxel—melanoma	0.000615	0.00407	CcSEcCtD
Estropipate—Breast disorder—Temozolomide—melanoma	0.000607	0.00401	CcSEcCtD
Estropipate—Acute coronary syndrome—Bleomycin—melanoma	0.000605	0.004	CcSEcCtD
Estropipate—Myocardial infarction—Bleomycin—melanoma	0.000601	0.00398	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000588	0.00389	CcSEcCtD
Estropipate—Abdominal distension—Temozolomide—melanoma	0.000584	0.00386	CcSEcCtD
Estropipate—Fluid retention—Docetaxel—melanoma	0.000584	0.00386	CcSEcCtD
Estropipate—Gastrointestinal disorder—Vemurafenib—melanoma	0.000558	0.00369	CcSEcCtD
Estropipate—Fatigue—Vemurafenib—melanoma	0.000557	0.00368	CcSEcCtD
Estropipate—Neoplasm—Docetaxel—melanoma	0.000556	0.00368	CcSEcCtD
Estropipate—Constipation—Vemurafenib—melanoma	0.000552	0.00365	CcSEcCtD
Estropipate—Estrone—CYP1B1—melanoma	0.000549	0.0967	CrCbGaD
Estropipate—Dysuria—Temozolomide—melanoma	0.000543	0.00359	CcSEcCtD
Estropipate—Hyperglycaemia—Carmustine—melanoma	0.000542	0.00358	CcSEcCtD
Estropipate—Upper respiratory tract infection—Temozolomide—melanoma	0.000539	0.00357	CcSEcCtD
Estropipate—Depression—Carmustine—melanoma	0.000534	0.00353	CcSEcCtD
Estropipate—Weight increased—Temozolomide—melanoma	0.000528	0.00349	CcSEcCtD
Estropipate—Neuropathy peripheral—Carmustine—melanoma	0.000525	0.00347	CcSEcCtD
Estropipate—Hyperglycaemia—Temozolomide—melanoma	0.000524	0.00346	CcSEcCtD
Estropipate—Infestation—Temozolomide—melanoma	0.000518	0.00342	CcSEcCtD
Estropipate—Infestation NOS—Temozolomide—melanoma	0.000518	0.00342	CcSEcCtD
Estropipate—Depression—Temozolomide—melanoma	0.000516	0.00341	CcSEcCtD
Estropipate—Thrombophlebitis—Docetaxel—melanoma	0.000516	0.00341	CcSEcCtD
Estropipate—Body temperature increased—Vemurafenib—melanoma	0.000511	0.00338	CcSEcCtD
Estropipate—Pharyngitis—Dactinomycin—melanoma	0.00051	0.00337	CcSEcCtD
Estropipate—Neuropathy peripheral—Temozolomide—melanoma	0.000507	0.00335	CcSEcCtD
Estropipate—Hepatobiliary disease—Temozolomide—melanoma	0.000489	0.00324	CcSEcCtD
Estropipate—Alopecia—Bleomycin—melanoma	0.000487	0.00322	CcSEcCtD
Estropipate—Erythema multiforme—Dactinomycin—melanoma	0.000486	0.00321	CcSEcCtD
Estropipate—Sinusitis—Temozolomide—melanoma	0.000486	0.00321	CcSEcCtD
Estropipate—Erythema—Bleomycin—melanoma	0.000479	0.00317	CcSEcCtD
Estropipate—Hypersensitivity—Vemurafenib—melanoma	0.000476	0.00315	CcSEcCtD
Estropipate—Oedema peripheral—Carmustine—melanoma	0.000474	0.00313	CcSEcCtD
Estropipate—Visual disturbance—Docetaxel—melanoma	0.000471	0.00312	CcSEcCtD
Estropipate—Dermatitis bullous—Docetaxel—melanoma	0.000467	0.00309	CcSEcCtD
Estropipate—Asthenia—Vemurafenib—melanoma	0.000463	0.00306	CcSEcCtD
Estropipate—Visual impairment—Carmustine—melanoma	0.000463	0.00306	CcSEcCtD
Estropipate—Pharyngitis—Temozolomide—melanoma	0.000461	0.00305	CcSEcCtD
Estropipate—Oedema peripheral—Temozolomide—melanoma	0.000458	0.00303	CcSEcCtD
Estropipate—Pruritus—Vemurafenib—melanoma	0.000457	0.00302	CcSEcCtD
Estropipate—Alopecia—Dactinomycin—melanoma	0.000454	0.003	CcSEcCtD
Estropipate—Eye disorder—Carmustine—melanoma	0.000449	0.00297	CcSEcCtD
Estropipate—Visual impairment—Temozolomide—melanoma	0.000448	0.00296	CcSEcCtD
Estropipate—Erythema—Dactinomycin—melanoma	0.000447	0.00296	CcSEcCtD
Estropipate—Pain in extremity—Docetaxel—melanoma	0.000447	0.00295	CcSEcCtD
Estropipate—Diarrhoea—Vemurafenib—melanoma	0.000442	0.00292	CcSEcCtD
Estropipate—Migraine—Docetaxel—melanoma	0.00044	0.00291	CcSEcCtD
Estropipate—Erythema multiforme—Temozolomide—melanoma	0.000439	0.0029	CcSEcCtD
Estropipate—Eye disorder—Temozolomide—melanoma	0.000434	0.00287	CcSEcCtD
Estropipate—Cardiac disorder—Temozolomide—melanoma	0.000431	0.00285	CcSEcCtD
Estropipate—Dizziness—Vemurafenib—melanoma	0.000427	0.00282	CcSEcCtD
Estropipate—Alopecia—Carmustine—melanoma	0.000425	0.00281	CcSEcCtD
Estropipate—Angiopathy—Temozolomide—melanoma	0.000421	0.00279	CcSEcCtD
Estropipate—Mental disorder—Carmustine—melanoma	0.000421	0.00278	CcSEcCtD
Estropipate—Immune system disorder—Temozolomide—melanoma	0.00042	0.00277	CcSEcCtD
Estropipate—Mediastinal disorder—Temozolomide—melanoma	0.000419	0.00277	CcSEcCtD
Estropipate—Malnutrition—Carmustine—melanoma	0.000418	0.00277	CcSEcCtD
Estropipate—Erythema—Carmustine—melanoma	0.000418	0.00277	CcSEcCtD
Estropipate—Cough—Bleomycin—melanoma	0.000418	0.00277	CcSEcCtD
Estropipate—Estradiol—CYP1B1—melanoma	0.000416	0.0733	CrCbGaD
Estropipate—Vomiting—Vemurafenib—melanoma	0.000411	0.00272	CcSEcCtD
Estropipate—Alopecia—Temozolomide—melanoma	0.000411	0.00271	CcSEcCtD
Estropipate—Myalgia—Bleomycin—melanoma	0.000408	0.0027	CcSEcCtD
Estropipate—Rash—Vemurafenib—melanoma	0.000407	0.00269	CcSEcCtD
Estropipate—Mental disorder—Temozolomide—melanoma	0.000407	0.00269	CcSEcCtD
Estropipate—Dermatitis—Vemurafenib—melanoma	0.000407	0.00269	CcSEcCtD
Estropipate—Back pain—Carmustine—melanoma	0.000405	0.00268	CcSEcCtD
Estropipate—Headache—Vemurafenib—melanoma	0.000405	0.00268	CcSEcCtD
Estropipate—Malnutrition—Temozolomide—melanoma	0.000404	0.00267	CcSEcCtD
Estropipate—Erythema—Temozolomide—melanoma	0.000404	0.00267	CcSEcCtD
Estropipate—Breast disorder—Docetaxel—melanoma	0.000404	0.00267	CcSEcCtD
Estropipate—Cramp muscle—Docetaxel—melanoma	0.000402	0.00266	CcSEcCtD
Estropipate—Oedema—Bleomycin—melanoma	0.000391	0.00259	CcSEcCtD
Estropipate—Anaphylactic shock—Bleomycin—melanoma	0.000391	0.00259	CcSEcCtD
Estropipate—Back pain—Temozolomide—melanoma	0.000391	0.00259	CcSEcCtD
Estropipate—Infection—Bleomycin—melanoma	0.000389	0.00257	CcSEcCtD
Estropipate—Nausea—Vemurafenib—melanoma	0.000384	0.00254	CcSEcCtD
Estropipate—Myalgia—Dactinomycin—melanoma	0.000381	0.00252	CcSEcCtD
Estropipate—Angioedema—Temozolomide—melanoma	0.00037	0.00244	CcSEcCtD
Estropipate—Oedema—Dactinomycin—melanoma	0.000365	0.00241	CcSEcCtD
Estropipate—Vertigo—Temozolomide—melanoma	0.000363	0.0024	CcSEcCtD
Estropipate—Infection—Dactinomycin—melanoma	0.000363	0.0024	CcSEcCtD
Estropipate—Palpitations—Temozolomide—melanoma	0.000357	0.00236	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000356	0.00236	CcSEcCtD
Estropipate—Myalgia—Carmustine—melanoma	0.000356	0.00236	CcSEcCtD
Estropipate—Anxiety—Carmustine—melanoma	0.000355	0.00235	CcSEcCtD
Estropipate—Cough—Temozolomide—melanoma	0.000353	0.00233	CcSEcCtD
Estropipate—Paraesthesia—Bleomycin—melanoma	0.000351	0.00232	CcSEcCtD
Estropipate—Weight increased—Docetaxel—melanoma	0.000351	0.00232	CcSEcCtD
Estropipate—Arthralgia—Temozolomide—melanoma	0.000344	0.00228	CcSEcCtD
Estropipate—Myalgia—Temozolomide—melanoma	0.000344	0.00228	CcSEcCtD
Estropipate—Infestation NOS—Docetaxel—melanoma	0.000344	0.00228	CcSEcCtD
Estropipate—Infestation—Docetaxel—melanoma	0.000344	0.00228	CcSEcCtD
Estropipate—Anxiety—Temozolomide—melanoma	0.000343	0.00227	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000342	0.00226	CcSEcCtD
Estropipate—Oedema—Carmustine—melanoma	0.000342	0.00226	CcSEcCtD
Estropipate—Infection—Carmustine—melanoma	0.000339	0.00224	CcSEcCtD
Estropipate—Acute coronary syndrome—Docetaxel—melanoma	0.000339	0.00224	CcSEcCtD
Estropipate—Myocardial infarction—Docetaxel—melanoma	0.000337	0.00223	CcSEcCtD
Estropipate—Neuropathy peripheral—Docetaxel—melanoma	0.000337	0.00223	CcSEcCtD
Estropipate—Pain—Bleomycin—melanoma	0.000335	0.00221	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000332	0.0022	CcSEcCtD
Estropipate—Estriol—ABCB1—melanoma	0.000331	0.0583	CrCbGaD
Estropipate—Anaphylactic shock—Temozolomide—melanoma	0.00033	0.00218	CcSEcCtD
Estropipate—Oedema—Temozolomide—melanoma	0.00033	0.00218	CcSEcCtD
Estropipate—Infection—Temozolomide—melanoma	0.000328	0.00217	CcSEcCtD
Estropipate—Hepatobiliary disease—Docetaxel—melanoma	0.000325	0.00215	CcSEcCtD
Estropipate—Nervous system disorder—Temozolomide—melanoma	0.000324	0.00214	CcSEcCtD
Estropipate—Skin disorder—Temozolomide—melanoma	0.000321	0.00212	CcSEcCtD
Estropipate—Fatigue—Dactinomycin—melanoma	0.000315	0.00208	CcSEcCtD
Estropipate—Pain—Dactinomycin—melanoma	0.000312	0.00206	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Carmustine—melanoma	0.000311	0.00206	CcSEcCtD
Estropipate—Urticaria—Bleomycin—melanoma	0.000311	0.00206	CcSEcCtD
Estropipate—Rhinitis—Docetaxel—melanoma	0.00031	0.00205	CcSEcCtD
Estropipate—Body temperature increased—Bleomycin—melanoma	0.000309	0.00205	CcSEcCtD
Estropipate—Insomnia—Carmustine—melanoma	0.000309	0.00204	CcSEcCtD
Estropipate—Estramustine—ABCB1—melanoma	0.000308	0.0542	CrCbGaD
Estropipate—Paraesthesia—Carmustine—melanoma	0.000307	0.00203	CcSEcCtD
Estropipate—Pharyngitis—Docetaxel—melanoma	0.000307	0.00203	CcSEcCtD
Estropipate—Oedema peripheral—Docetaxel—melanoma	0.000304	0.00201	CcSEcCtD
Estropipate—Somnolence—Carmustine—melanoma	0.000304	0.00201	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000301	0.00199	CcSEcCtD
Estropipate—Insomnia—Temozolomide—melanoma	0.000299	0.00197	CcSEcCtD
Estropipate—Gastrointestinal pain—Dactinomycin—melanoma	0.000298	0.00197	CcSEcCtD
Estropipate—Visual impairment—Docetaxel—melanoma	0.000298	0.00197	CcSEcCtD
Estropipate—Paraesthesia—Temozolomide—melanoma	0.000296	0.00196	CcSEcCtD
Estropipate—Gastrointestinal disorder—Carmustine—melanoma	0.000295	0.00195	CcSEcCtD
Estropipate—Somnolence—Temozolomide—melanoma	0.000293	0.00194	CcSEcCtD
Estropipate—Erythema multiforme—Docetaxel—melanoma	0.000292	0.00193	CcSEcCtD
Estropipate—Pain—Carmustine—melanoma	0.000292	0.00193	CcSEcCtD
Estropipate—Constipation—Carmustine—melanoma	0.000292	0.00193	CcSEcCtD
Estropipate—Dyspepsia—Temozolomide—melanoma	0.000291	0.00192	CcSEcCtD
Estropipate—Eye disorder—Docetaxel—melanoma	0.000289	0.00191	CcSEcCtD
Estropipate—Body temperature increased—Dactinomycin—melanoma	0.000288	0.00191	CcSEcCtD
Estropipate—Abdominal pain—Dactinomycin—melanoma	0.000288	0.00191	CcSEcCtD
Estropipate—Hypersensitivity—Bleomycin—melanoma	0.000288	0.00191	CcSEcCtD
Estropipate—Cardiac disorder—Docetaxel—melanoma	0.000287	0.0019	CcSEcCtD
Estropipate—Gastrointestinal disorder—Temozolomide—melanoma	0.000285	0.00188	CcSEcCtD
Estropipate—Fatigue—Temozolomide—melanoma	0.000285	0.00188	CcSEcCtD
Estropipate—Pain—Temozolomide—melanoma	0.000282	0.00187	CcSEcCtD
Estropipate—Constipation—Temozolomide—melanoma	0.000282	0.00187	CcSEcCtD
Estropipate—Asthenia—Bleomycin—melanoma	0.000281	0.00186	CcSEcCtD
Estropipate—Angiopathy—Docetaxel—melanoma	0.00028	0.00185	CcSEcCtD
Estropipate—Gastrointestinal pain—Carmustine—melanoma	0.000279	0.00185	CcSEcCtD
Estropipate—Immune system disorder—Docetaxel—melanoma	0.000279	0.00185	CcSEcCtD
Estropipate—Mediastinal disorder—Docetaxel—melanoma	0.000278	0.00184	CcSEcCtD
Estropipate—Pruritus—Bleomycin—melanoma	0.000277	0.00183	CcSEcCtD
Estropipate—Alopecia—Docetaxel—melanoma	0.000273	0.00181	CcSEcCtD
Estropipate—Mental disorder—Docetaxel—melanoma	0.000271	0.00179	CcSEcCtD
Estropipate—Abdominal pain—Carmustine—melanoma	0.00027	0.00179	CcSEcCtD
Estropipate—Body temperature increased—Carmustine—melanoma	0.00027	0.00179	CcSEcCtD
Estropipate—Gastrointestinal pain—Temozolomide—melanoma	0.00027	0.00178	CcSEcCtD
Estropipate—Erythema—Docetaxel—melanoma	0.000269	0.00178	CcSEcCtD
Estropipate—Malnutrition—Docetaxel—melanoma	0.000269	0.00178	CcSEcCtD
Estropipate—Hypersensitivity—Dactinomycin—melanoma	0.000269	0.00178	CcSEcCtD
Estropipate—Urticaria—Temozolomide—melanoma	0.000262	0.00173	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—melanoma	0.000262	0.00173	CcSEcCtD
Estropipate—Abdominal pain—Temozolomide—melanoma	0.000261	0.00173	CcSEcCtD
Estropipate—Body temperature increased—Temozolomide—melanoma	0.000261	0.00173	CcSEcCtD
Estropipate—Back pain—Docetaxel—melanoma	0.00026	0.00172	CcSEcCtD
Estropipate—Muscle spasms—Docetaxel—melanoma	0.000259	0.00171	CcSEcCtD
Estropipate—Hypersensitivity—Carmustine—melanoma	0.000252	0.00166	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—melanoma	0.00025	0.00165	CcSEcCtD
Estropipate—Vomiting—Bleomycin—melanoma	0.000249	0.00165	CcSEcCtD
Estropipate—Rash—Bleomycin—melanoma	0.000247	0.00163	CcSEcCtD
Estropipate—Dermatitis—Bleomycin—melanoma	0.000246	0.00163	CcSEcCtD
Estropipate—Asthenia—Carmustine—melanoma	0.000245	0.00162	CcSEcCtD
Estropipate—Hypersensitivity—Temozolomide—melanoma	0.000243	0.00161	CcSEcCtD
Estropipate—Palpitations—Docetaxel—melanoma	0.000238	0.00157	CcSEcCtD
Estropipate—Asthenia—Temozolomide—melanoma	0.000237	0.00157	CcSEcCtD
Estropipate—Cough—Docetaxel—melanoma	0.000235	0.00155	CcSEcCtD
Estropipate—Diarrhoea—Carmustine—melanoma	0.000234	0.00155	CcSEcCtD
Estropipate—Pruritus—Temozolomide—melanoma	0.000234	0.00154	CcSEcCtD
Estropipate—Nausea—Bleomycin—melanoma	0.000232	0.00154	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—melanoma	0.000232	0.00153	CcSEcCtD
Estropipate—Rash—Dactinomycin—melanoma	0.00023	0.00152	CcSEcCtD
Estropipate—Arthralgia—Docetaxel—melanoma	0.000229	0.00151	CcSEcCtD
Estropipate—Myalgia—Docetaxel—melanoma	0.000229	0.00151	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000227	0.0015	CcSEcCtD
Estropipate—Dizziness—Carmustine—melanoma	0.000226	0.00149	CcSEcCtD
Estropipate—Diarrhoea—Temozolomide—melanoma	0.000226	0.00149	CcSEcCtD
Estropipate—Oedema—Docetaxel—melanoma	0.000219	0.00145	CcSEcCtD
Estropipate—Anaphylactic shock—Docetaxel—melanoma	0.000219	0.00145	CcSEcCtD
Estropipate—Dizziness—Temozolomide—melanoma	0.000218	0.00144	CcSEcCtD
Estropipate—Infection—Docetaxel—melanoma	0.000218	0.00144	CcSEcCtD
Estropipate—Vomiting—Carmustine—melanoma	0.000217	0.00144	CcSEcCtD
Estropipate—Nausea—Dactinomycin—melanoma	0.000217	0.00143	CcSEcCtD
Estropipate—Rash—Carmustine—melanoma	0.000215	0.00142	CcSEcCtD
Estropipate—Nervous system disorder—Docetaxel—melanoma	0.000215	0.00142	CcSEcCtD
Estropipate—Dermatitis—Carmustine—melanoma	0.000215	0.00142	CcSEcCtD
Estropipate—Headache—Carmustine—melanoma	0.000214	0.00141	CcSEcCtD
Estropipate—Skin disorder—Docetaxel—melanoma	0.000213	0.00141	CcSEcCtD
Estropipate—Vomiting—Temozolomide—melanoma	0.00021	0.00139	CcSEcCtD
Estropipate—Rash—Temozolomide—melanoma	0.000208	0.00138	CcSEcCtD
Estropipate—Dermatitis—Temozolomide—melanoma	0.000208	0.00137	CcSEcCtD
Estropipate—Headache—Temozolomide—melanoma	0.000207	0.00137	CcSEcCtD
Estropipate—Nausea—Carmustine—melanoma	0.000203	0.00134	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Docetaxel—melanoma	0.0002	0.00132	CcSEcCtD
Estropipate—Insomnia—Docetaxel—melanoma	0.000199	0.00131	CcSEcCtD
Estropipate—Paraesthesia—Docetaxel—melanoma	0.000197	0.0013	CcSEcCtD
Estropipate—Nausea—Temozolomide—melanoma	0.000196	0.0013	CcSEcCtD
Estropipate—Somnolence—Docetaxel—melanoma	0.000195	0.00129	CcSEcCtD
Estropipate—Dyspepsia—Docetaxel—melanoma	0.000193	0.00128	CcSEcCtD
Estropipate—Gastrointestinal disorder—Docetaxel—melanoma	0.000189	0.00125	CcSEcCtD
Estropipate—Fatigue—Docetaxel—melanoma	0.000189	0.00125	CcSEcCtD
Estropipate—Constipation—Docetaxel—melanoma	0.000188	0.00124	CcSEcCtD
Estropipate—Pain—Docetaxel—melanoma	0.000188	0.00124	CcSEcCtD
Estropipate—Ethinyl Estradiol—ABCB1—melanoma	0.000181	0.0318	CrCbGaD
Estropipate—Gastrointestinal pain—Docetaxel—melanoma	0.000179	0.00119	CcSEcCtD
Estropipate—Abdominal pain—Docetaxel—melanoma	0.000174	0.00115	CcSEcCtD
Estropipate—Body temperature increased—Docetaxel—melanoma	0.000174	0.00115	CcSEcCtD
Estropipate—Estrone—ALB—melanoma	0.000165	0.0291	CrCbGaD
Estropipate—Hypersensitivity—Docetaxel—melanoma	0.000162	0.00107	CcSEcCtD
Estropipate—Conjugated Estrogens—ABCB1—melanoma	0.000158	0.0278	CrCbGaD
Estropipate—Asthenia—Docetaxel—melanoma	0.000157	0.00104	CcSEcCtD
Estropipate—Estrone—ABCB1—melanoma	0.000157	0.0277	CrCbGaD
Estropipate—Pruritus—Docetaxel—melanoma	0.000155	0.00103	CcSEcCtD
Estropipate—Diarrhoea—Docetaxel—melanoma	0.00015	0.000993	CcSEcCtD
Estropipate—Dizziness—Docetaxel—melanoma	0.000145	0.00096	CcSEcCtD
Estropipate—Vomiting—Docetaxel—melanoma	0.00014	0.000923	CcSEcCtD
Estropipate—Rash—Docetaxel—melanoma	0.000138	0.000915	CcSEcCtD
Estropipate—Dermatitis—Docetaxel—melanoma	0.000138	0.000914	CcSEcCtD
Estropipate—Headache—Docetaxel—melanoma	0.000138	0.000909	CcSEcCtD
Estropipate—Nausea—Docetaxel—melanoma	0.00013	0.000862	CcSEcCtD
Estropipate—Estradiol—ALB—melanoma	0.000125	0.022	CrCbGaD
Estropipate—Estradiol—ABCB1—melanoma	0.000119	0.021	CrCbGaD
Estropipate—SLC22A1—Metabolism—SLC5A5—melanoma	1.91e-05	0.000178	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PRKCA—melanoma	1.91e-05	0.000178	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CUBN—melanoma	1.91e-05	0.000178	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTAP—melanoma	1.9e-05	0.000177	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.9e-05	0.000177	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—ERCC2—melanoma	1.9e-05	0.000177	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTK2B—melanoma	1.89e-05	0.000176	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.86e-05	0.000173	CbGpPWpGaD
Estropipate—ALB—Metabolism—PLA2G6—melanoma	1.86e-05	0.000173	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CD44—melanoma	1.85e-05	0.000172	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GNAQ—melanoma	1.85e-05	0.000172	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SDHD—melanoma	1.84e-05	0.000172	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—BSG—melanoma	1.84e-05	0.000172	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CSPG4—melanoma	1.84e-05	0.000172	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GNA11—melanoma	1.84e-05	0.000172	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GAB2—melanoma	1.84e-05	0.000172	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FLT1—melanoma	1.83e-05	0.000171	CbGpPWpGaD
Estropipate—ALB—Hemostasis—FN1—melanoma	1.81e-05	0.000169	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.81e-05	0.000169	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—melanoma	1.8e-05	0.000168	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NOS2—melanoma	1.79e-05	0.000167	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GPAM—melanoma	1.79e-05	0.000167	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP1B1—melanoma	1.77e-05	0.000165	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CG—melanoma	1.73e-05	0.000162	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HDAC2—melanoma	1.73e-05	0.000161	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FOXO4—melanoma	1.73e-05	0.000161	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCR4—melanoma	1.73e-05	0.000161	CbGpPWpGaD
Estropipate—ALB—Hemostasis—EGF—melanoma	1.71e-05	0.00016	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—MYC—melanoma	1.71e-05	0.00016	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GNAQ—melanoma	1.71e-05	0.00016	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PHGDH—melanoma	1.7e-05	0.000158	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—LUM—melanoma	1.7e-05	0.000158	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MAPK3—melanoma	1.68e-05	0.000157	CbGpPWpGaD
Estropipate—ALB—Metabolism—VCAN—melanoma	1.67e-05	0.000156	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HPSE—melanoma	1.66e-05	0.000155	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MYC—melanoma	1.63e-05	0.000152	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CUBN—melanoma	1.63e-05	0.000152	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SYK—melanoma	1.61e-05	0.00015	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PLCB4—melanoma	1.61e-05	0.00015	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IGF1—melanoma	1.59e-05	0.000148	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT3—melanoma	1.58e-05	0.000147	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ITGAV—melanoma	1.58e-05	0.000147	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NGFR—melanoma	1.58e-05	0.000147	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.58e-05	0.000147	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SDHD—melanoma	1.58e-05	0.000147	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—BSG—melanoma	1.58e-05	0.000147	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CSPG4—melanoma	1.58e-05	0.000147	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.57e-05	0.000147	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—NOTCH1—melanoma	1.53e-05	0.000143	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GPAM—melanoma	1.53e-05	0.000142	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CD—melanoma	1.52e-05	0.000142	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.52e-05	0.000142	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PLA2G6—melanoma	1.52e-05	0.000142	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC6A11—melanoma	1.51e-05	0.000141	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIP4K2A—melanoma	1.51e-05	0.000141	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTAP—melanoma	1.47e-05	0.000137	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SOCS1—melanoma	1.46e-05	0.000136	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—S100B—melanoma	1.46e-05	0.000136	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ABCB1—melanoma	1.46e-05	0.000136	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPARG—melanoma	1.44e-05	0.000135	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP17A1—melanoma	1.41e-05	0.000131	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB4—melanoma	1.39e-05	0.00013	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.39e-05	0.000129	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN2B—melanoma	1.38e-05	0.000129	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—VCAN—melanoma	1.36e-05	0.000127	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PRKCA—melanoma	1.34e-05	0.000125	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD86—melanoma	1.34e-05	0.000125	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ERCC2—melanoma	1.33e-05	0.000124	CbGpPWpGaD
Estropipate—ALB—Metabolism—GNA11—melanoma	1.33e-05	0.000124	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CB—melanoma	1.33e-05	0.000124	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EDN1—melanoma	1.33e-05	0.000124	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PHGDH—melanoma	1.31e-05	0.000122	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—LUM—melanoma	1.31e-05	0.000122	CbGpPWpGaD
Estropipate—ALB—Metabolism—FASN—melanoma	1.3e-05	0.000121	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PLA2G6—melanoma	1.3e-05	0.000121	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CSF2—melanoma	1.3e-05	0.000121	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGF1—melanoma	1.3e-05	0.000121	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.29e-05	0.00012	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HPSE—melanoma	1.28e-05	0.00012	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.28e-05	0.00012	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC5A5—melanoma	1.28e-05	0.000119	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—E2F1—melanoma	1.27e-05	0.000118	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CUBN—melanoma	1.26e-05	0.000118	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PDGFRA—melanoma	1.26e-05	0.000117	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.25e-05	0.000116	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ITGB3—melanoma	1.24e-05	0.000116	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PRKCA—melanoma	1.24e-05	0.000116	CbGpPWpGaD
Estropipate—ALB—Metabolism—GNAQ—melanoma	1.23e-05	0.000115	CbGpPWpGaD
Estropipate—ALB—Metabolism—CD44—melanoma	1.23e-05	0.000115	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—melanoma	1.22e-05	0.000114	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SPP1—melanoma	1.22e-05	0.000114	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CSPG4—melanoma	1.22e-05	0.000113	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SDHD—melanoma	1.22e-05	0.000113	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—BSG—melanoma	1.22e-05	0.000113	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAP2K2—melanoma	1.21e-05	0.000113	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.21e-05	0.000113	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.2e-05	0.000112	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1B1—melanoma	1.18e-05	0.00011	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GPAM—melanoma	1.18e-05	0.00011	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—VCAN—melanoma	1.17e-05	0.000109	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—melanoma	1.16e-05	0.000108	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—RAC1—melanoma	1.15e-05	0.000107	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP17A1—melanoma	1.15e-05	0.000107	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.14e-05	0.000106	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—melanoma	1.13e-05	0.000106	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.12e-05	0.000105	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HIF1A—melanoma	1.1e-05	0.000103	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.1e-05	0.000103	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GNA11—melanoma	1.09e-05	0.000101	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.07e-05	9.94e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—FASN—melanoma	1.06e-05	9.93e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KDR—melanoma	1.06e-05	9.85e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CG—melanoma	1.05e-05	9.8e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC5A5—melanoma	1.05e-05	9.76e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.04e-05	9.75e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—melanoma	1.04e-05	9.67e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—melanoma	1.02e-05	9.55e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FN1—melanoma	1.02e-05	9.49e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPARG—melanoma	1.01e-05	9.46e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GNAQ—melanoma	1.01e-05	9.43e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CD44—melanoma	1.01e-05	9.43e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PLA2G6—melanoma	1e-05	9.35e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NOTCH1—melanoma	9.95e-06	9.28e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.9e-06	9.23e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP17A1—melanoma	9.84e-06	9.18e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.81e-06	9.15e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK3—melanoma	9.81e-06	9.15e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—ABCB1—melanoma	9.75e-06	9.09e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD80—melanoma	9.75e-06	9.09e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CG—melanoma	9.73e-06	9.08e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APC—melanoma	9.73e-06	9.08e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KIT—melanoma	9.73e-06	9.08e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.7e-06	9.05e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1B1—melanoma	9.69e-06	9.04e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGF—melanoma	9.62e-06	8.97e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	9.58e-06	8.94e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK1—melanoma	9.33e-06	8.7e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GNA11—melanoma	9.29e-06	8.67e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CD—melanoma	9.24e-06	8.62e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—melanoma	9.15e-06	8.53e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALB—melanoma	9.12e-06	8.51e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—FASN—melanoma	9.09e-06	8.48e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—VCAN—melanoma	9e-06	8.4e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PRKCA—melanoma	8.97e-06	8.37e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC5A5—melanoma	8.94e-06	8.34e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1—melanoma	8.91e-06	8.31e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—ERCC2—melanoma	8.9e-06	8.3e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—melanoma	8.81e-06	8.22e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GNAQ—melanoma	8.64e-06	8.06e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CD44—melanoma	8.64e-06	8.06e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAP2K1—melanoma	8.61e-06	8.03e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CD—melanoma	8.56e-06	7.98e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.55e-06	7.98e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MAPK3—melanoma	8.47e-06	7.9e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.46e-06	7.89e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.38e-06	7.82e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1B1—melanoma	8.28e-06	7.73e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—melanoma	8.24e-06	7.68e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGF2—melanoma	8.19e-06	7.64e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—melanoma	8.1e-06	7.55e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CB—melanoma	8.05e-06	7.51e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCB1—melanoma	7.98e-06	7.44e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—melanoma	7.98e-06	7.44e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—melanoma	7.83e-06	7.31e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MDM2—melanoma	7.66e-06	7.15e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP17A1—melanoma	7.59e-06	7.08e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—melanoma	7.56e-06	7.05e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—melanoma	7.49e-06	6.99e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CB—melanoma	7.46e-06	6.96e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.37e-06	6.88e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PRKCA—melanoma	7.34e-06	6.85e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.31e-06	6.82e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ERCC2—melanoma	7.28e-06	6.79e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GNA11—melanoma	7.17e-06	6.69e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—melanoma	7.17e-06	6.68e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CG—melanoma	7.03e-06	6.56e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—FASN—melanoma	7.02e-06	6.55e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1B—melanoma	7e-06	6.53e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—melanoma	6.96e-06	6.49e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC5A5—melanoma	6.9e-06	6.44e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—melanoma	6.86e-06	6.4e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—melanoma	6.85e-06	6.39e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCB1—melanoma	6.82e-06	6.36e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARG—melanoma	6.78e-06	6.33e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—melanoma	6.68e-06	6.23e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CD44—melanoma	6.67e-06	6.22e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GNAQ—melanoma	6.67e-06	6.22e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—melanoma	6.61e-06	6.17e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—melanoma	6.61e-06	6.17e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—melanoma	6.48e-06	6.05e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1A—melanoma	6.46e-06	6.02e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—melanoma	6.44e-06	6.01e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NFKB1—melanoma	6.41e-06	5.98e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1B1—melanoma	6.39e-06	5.96e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PRKCA—melanoma	6.28e-06	5.85e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ERCC2—melanoma	6.22e-06	5.81e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CD—melanoma	6.18e-06	5.76e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.03e-06	5.63e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—melanoma	5.82e-06	5.43e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—melanoma	5.76e-06	5.38e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CG—melanoma	5.75e-06	5.37e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—melanoma	5.75e-06	5.36e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—melanoma	5.71e-06	5.33e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARG—melanoma	5.55e-06	5.18e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK3—melanoma	5.51e-06	5.14e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CB—melanoma	5.39e-06	5.02e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—melanoma	5.35e-06	5e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—melanoma	5.34e-06	4.98e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCB1—melanoma	5.26e-06	4.91e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK1—melanoma	5.24e-06	4.89e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—melanoma	5.24e-06	4.89e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.16e-06	4.81e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CD—melanoma	5.06e-06	4.72e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALB—melanoma	4.99e-06	4.66e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—melanoma	4.95e-06	4.62e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CG—melanoma	4.92e-06	4.59e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—melanoma	4.91e-06	4.58e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PRKCA—melanoma	4.84e-06	4.52e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ERCC2—melanoma	4.8e-06	4.48e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARG—melanoma	4.74e-06	4.43e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—melanoma	4.65e-06	4.34e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—melanoma	4.55e-06	4.24e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CB—melanoma	4.41e-06	4.11e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—melanoma	4.4e-06	4.1e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—melanoma	4.37e-06	4.07e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CD—melanoma	4.32e-06	4.03e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALB—melanoma	4.27e-06	3.98e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—melanoma	4.21e-06	3.92e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—melanoma	4.03e-06	3.75e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—melanoma	4.01e-06	3.74e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—melanoma	3.81e-06	3.55e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CG—melanoma	3.79e-06	3.54e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CB—melanoma	3.77e-06	3.51e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—melanoma	3.73e-06	3.48e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—melanoma	3.71e-06	3.46e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARG—melanoma	3.66e-06	3.42e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CD—melanoma	3.34e-06	3.11e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALB—melanoma	3.29e-06	3.07e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—melanoma	3.28e-06	3.06e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—melanoma	3.25e-06	3.04e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CB—melanoma	2.91e-06	2.71e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—melanoma	2.88e-06	2.69e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—melanoma	2.69e-06	2.51e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—melanoma	2.68e-06	2.5e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—melanoma	2.51e-06	2.34e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—melanoma	2.3e-06	2.14e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—melanoma	2.2e-06	2.05e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—melanoma	1.88e-06	1.75e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—melanoma	1.77e-06	1.65e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—melanoma	1.45e-06	1.35e-05	CbGpPWpGaD
